首頁 > 市場調查報告書 > 醫療設備

整形外科

市場調查報告書

商品編碼

1606537

全球手術網片市場 - 2024-2031

Global Surgical Mesh Market - 2024-2031

出版日期: 2024年12月04日 | 出版商:

DataM Intelligence | 英文 176 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

概述

2023年，全球手術網片市場達到19.0億美元，預計2031年將達到32.2億美元，2024-2031年預測期間複合年成長率為6.9%。

手術網片是一種用於外科手術的醫療器械，可為虛弱或受損的組織提供額外的支撐。它通常是由合成或生物材料製成的軟性片狀結構，旨在在癒合過程中加固和穩定組織。手術網片廣泛應用於各種外科手術，包括疝氣修補、骨盆器官脫垂（POP）修復、壓力性尿失禁（SUI）治療和其他重建手術。網片有多種結構，例如單絲、複絲和複合網片，以滿足特定的手術需求。

多年來，尤其是由於疝氣修復手術的不斷增加，手術網片市場的需求量很大。例如，根據美國食品藥物管理局 (FDA) 的數據，美國每年進行超過 100 萬例疝氣修補手術，而全世界每年此類手術估計超過 2,000 萬例，這些修復手術涉及使用手術網片，使其成為疝氣手術的護理標準，導致手術網片的需求增加。

市場動態：

驅動程式和限制

疝氣盛行率上升

疝氣盛行率的上升極大地推動了手術網片市場的發展，因為疝氣修復是網狀植入物最常見的手術應用之一。疝氣是一種器官或組織經由周圍肌肉或結締組織的薄弱點凸出的疾病。例如，aLLSurgical 網片用於加強薄弱區域，確保更好的恢復效果並降低復發風險。

此外，疝氣修補術是全世界最常見的手術類型之一。根據美國食品藥物管理局 (FDA) 統計，全球每年進行約 2,000 萬例疝氣修復手術。這種高產量直接推動了對這些手術中使用的手術網片的需求，特別是腹股溝、臍和腹部疝氣。

手術網片被認為是疝氣修復的黃金標準，因為它能夠為組織提供長期加固。 80% 的疝氣修補手術都涉及使用補片，因為它有助於防止復發並加速恢復。疝氣手術中對網狀植入物的偏好極大地促進了手術網狀市場的成長。

併發症和安全問題

與手術網片相關的併發症和安全問題預計將阻礙手術網片市場的成長。這些擔憂圍繞著網片遷移、感染、侵蝕、慢性疼痛和長期健康併發症等問題，所有這些都可能導致患者出現負面結果並增加醫療費用。圍繞手術網片的不良事件和安全問題日益增多，引發了監管審查和法律挑戰，這可能會減緩網片產品的採用。

當網狀材料分解或從其原始位置移動時，就會發生網狀侵蝕，導致其嵌入附近的組織或器官。這可能導致嚴重的併發症，例如感染、慢性疼痛和組織損傷。同樣，網片遷移是指網片偏離其預期位置的移動，這也可能導致內部損壞並需要進行矯正手術。

例如，研究顯示 5% 至 20% 的疝氣手術會導致補片失敗。根據《英國醫學雜誌》的一項研究，這一比例可能在 12% 到 30% 之間。這些併發症可能需要進行翻修手術，這會增加醫療費用和患者發病率。

Surgical mesh is a medical device used in surgical procedures to provide additional support to weakened or damaged tissue. It is typically a flexible, sheet-like structure made from synthetic or biological materials and is designed to reinforce and stabilize tissues during healing. Surgical meshes are widely used in various surgical applications, including hernia repair, pelvic organ prolapse (POP) repair, stress urinary incontinence (SUI) treatment and other reconstructive surgeries. Meshes are available in various structures, such as monofilament, multifilament and composite meshes, to cater to specific surgical needs.

The surgical mesh market has witnessed substantial demand over the years owing to the rising hernia repairs, especially. For instance, according to the U.S. Food and Drug Administration (FDA), more than 1 million hernia repairs are performed each year in the United States, and worldwide these surgeries are estimated to top 20 million annually, these repairs involve the use of surgical mesh, making it the standard of care for hernia surgery, contributing to the increasing demand for surgical meshes.

Market Dynamics: Drivers & Restraints

Rising prevalence of hernias

The rising prevalence of hernias is significantly driving the surgical mesh market, as hernia repairs are one of the most common surgical applications for mesh implants. Hernia is a condition in which an organ or tissue bulges through a weak spot in the surrounding muscle or connective tissue. For instance, aLLSurgical mesh is used to reinforce the weakened area, ensuring better recovery outcomes and reducing the risk of recurrence.

Additionally, hernia repairs are among the most common types of surgeries performed worldwide. According to the U.S. Food and Drug Administration (FDA), annually, about 20 million hernia repairs are conducted globally. This high volume directly drives demand for surgical meshes used in these procedures, especially for inguinal, umbilical, and ventral hernias.

Surgical mesh is considered the gold standard for hernia repair due to its ability to provide long-term reinforcement to the tissue. 80% of all hernia repairs involve the use of mesh, as it helps prevent recurrence and speeds up recovery. This preference for mesh implants in hernia surgeries significantly contributes to the growth of the surgical mesh market.

Complications and safety concerns

Complications and safety concerns related to surgical mesh are expected to hamper the growth of the surgical mesh market. These concerns revolve around issues such as mesh migration, infection, erosion, chronic pain and long-term health complications, all of which can lead to negative patient outcomes and increased healthcare costs. The growing number of adverse events and safety concerns surrounding surgical meshes has prompted regulatory scrutiny and legal challenges, which can slow the adoption of mesh products.

Mesh erosion occurs when the mesh material degrades or moves from its original position, causing it to become embedded in nearby tissues or organs. This can lead to severe complications such as infection, chronic pain, and tissue damage. Similarly, mesh migration refers to the movement of the mesh from its intended placement, which can also cause internal damage and necessitate corrective surgery.

For instance, studies suggest that 5% to 20% of hernia operations result in mesh failure. According to a study in the British Medical Journal, the rate could be between 12% and 30%. These complications may require revision surgeries, which can increase both healthcare costs and patient morbidity.

Segment Analysis

The global surgical mesh market is segmented based on product type, material type, application, end-user and region.

Application:

The hernia repair segment is expected to dominate the global surgical mesh market share

The hernia repair segment holds a major portion of the surgical mesh market share and is expected to continue to hold a significant portion of the market share over the forecast period due to the established use of mesh in hernia repair surgeries and the superior outcomes provided by mesh-based procedures compared to traditional non-mesh surgeries. Hernia repair surgeries are the gold standard for reinforcing the weakened abdominal walls and preventing hernia recurrence. Thus, the market players are focusing on surgical mesh development due to its wide advantages.

For instance, in November 2024, Deep Blue Medical expanded its success of T-Line Hernia Mesh, a surgical product that helps prevent the recurrence of hernias after abdominal hernia repair surgery. Although the T-Line Mesh made its clinical debut just three years ago, it is already being used by about 45 clinical sites in the United States and over 8,000 of the novel extensions and lockstitches of the mesh have been implanted to date with no adverse events.

The shift towards minimally invasive hernia repair surgeries, such as laparoscopic and robot-assisted surgery, has contributed to the dominance of the hernia repair segment. Surgical meshes are ideal for use in these procedures because they are lightweight, flexible and can be easily inserted through small incisions.

For instance, laparoscopic hernia repair is becoming the preferred technique for many surgeons due to its lower complication rates and quicker recovery. According to the Global Hernia Society, the laparoscopic approach accounts for about 60-70% of hernia surgeries in developed countries, driving the demand for surgical meshes tailored for these procedures.

With the increasing awareness of hernias and the effectiveness of mesh-based surgeries, more patients are seeking treatment, contributing to the growing demand for hernia repairs using mesh. Additionally, improvements in healthcare access in emerging economies have increased the number of hernia surgeries being performed in those regions.

For instance, in June 2021, BG Medical., the manufacturer and distributor of the 21st Century SURGIMESH Platform honored Hernia Awareness Month by partnering with CQInsights to pioneer a new approach that delivers better outcomes for patients, with a larger mission to share sustainable solutions that improve healthcare for everyone.

North America is expected to hold a significant position in the global surgical mesh market

North America represents the largest share of the global surgical mesh market in terms of both revenue generation and market size. The U.S., in particular, is the largest market within the region, driven by a combination of high demand for surgeries, advanced healthcare technologies, and a well-established healthcare system.

North America, particularly the United States, has a high incidence of hernias due to factors such as an aging population, high obesity rates, and sedentary lifestyles. This has led to a large number of hernia repairs, most of which involve surgical mesh. For instance, according to Healthcare Cost and Utilization Project data and the US Food and Drug Administration, an estimated 611,000 ventral and 1 million inguinal hernia repairs are performed each year in the US.

North America has high levels of healthcare awareness and access, which leads to an increased number of surgeries involving surgical mesh. Patients are more likely to seek treatment for conditions like hernias, knowing that advanced treatments, such as mesh implants, are available. Thus, the market players are focusing on launching the surgical mesh with technological advancements.

For instance, in April 2024, ELA Bio commercially launched the OviTex Inguinal Hernia Repair (IHR) mesh in the US. The Pennsylvania-based firm has specifically designed the robotic-compatible OviTex IHR surgical mesh for use in laparoscopic and inguinal hernia repair. It comes in a three or four layer anatomically shaped device or a three-layer rectangular device.

Asia Pacific is growing at the fastest pace in the surgical mesh market

The Asia Pacific region is experiencing the fastest growth in the surgical mesh market. The rising rates of obesity in countries like China and India, combined with an increasing number of abdominal hernia cases, are driving the demand for hernia repair surgeries. Obesity is a key risk factor for hernias, and with lifestyle changes, these conditions are becoming more prevalent in the Asia Pacific region, creating a significant market opportunity for surgical meshes.

For instance, according to the World Health Organization (WHO), the prevalence of obesity in Asia is rising rapidly. According to the Chinese BMI classification for overweight and obesity, 34.8% of the study population were overweight and 14.1% were obese. This growing rate of obesity significantly contributes to the increasing number of hernia cases and surgeries requiring mesh.

The Asia Pacific region has witnessed significant investments in healthcare infrastructure, particularly in countries like India, China and South Korea, where hospitals, surgical centers and medical device manufacturers are modernizing and expanding. This has made advanced surgical treatments, including mesh-based procedures, more accessible to the growing population.

For instance, in October 2024, Park Hospital, a multi-specialty healthcare provider performed a complex robotic-assisted surgery to save a 45-year-old man from a complicated diaphragmatic hernia. Robotic-assisted surgery allowed to safely reduce the herniated organs back into the abdominal cavity and repair the diaphragm with a large mesh, ensuring a stable closure. This increases the demand for surgical mesh in the region.

Competitive Landscape

The major global players in the surgical mesh market include Johnson & Johnson, B. Braun SE, Medtronic plc, Becton, Dickinson and Company, CITEC, W. L. Gore & Associates, Inc., Medcity Surgicals, Dolphin Sutures, Herniamesh S.r.l., Advin Health Care and among others.

Why Purchase the Report?

Pipeline & Innovations: Insights into clinical trials, product pipelines, and upcoming advancements.
Market Positioning: Analysis of product performance and growth potential for optimized strategies.
Real-World Evidence: Integration of patient feedback for enhanced product outcomes.
Physician Preferences: Insights into healthcare provider behaviors and adoption strategies.
Regulatory & Market Updates: Coverage of recent regulations, policies, and emerging technologies.
Competitive Insights: Analysis of market share, competitor strategies, and new entrants.
Pricing & Market Access: Review of pricing models, reimbursement trends, and access strategies.
Market Expansion: Strategies for entering new markets and forming partnerships.
Regional Opportunities: Identification of high-growth regions and investment prospects.
Supply Chain Optimization: Assessment of risks and distribution strategies.
Sustainability & Regulation: Focus on eco-friendly practices and regulatory changes.
Post-Market Surveillance: Enhanced safety and access through post-market data.
Value-Based Pricing: Insights into pharmacoeconomics and data-driven R&D decisions.

The global surgical mesh market report delivers a detailed analysis with 70 key tables, more than 66 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
Supply Chain: Distribution and Supply Chain Managers.
Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
Academic & Research: Academic Institutions.

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product Type
3.2. Snippet by Material Type
3.3. Snippet by Application
3.4. Snippet by End-User
3.5. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Rising Prevalence of Hernias
  - 4.1.1.2. Rising Innovations in Surgical Mesh Designs
- 4.1.2. Restraints
  - 4.1.2.1. Complications and Safety Concerns
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Patent Analysis
5.5. Regulatory Analysis
5.6. SWOT Analysis
5.7. Unmet Needs

6. By Product Type

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 6.1.2. Market Attractiveness Index, By Product Type
6.2. Absorbable Surgical Mesh*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Non-Absorbable Surgical Mesh
6.4. Biological Mesh
6.5. Synthetic Mesh

7. By Material Type

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
- 7.1.2. Market Attractiveness Index, By Material Type
7.2. Polypropylene*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Polyester
7.4. Polytetrafluoroethylene (PTFE)
7.5. Others

8. By Application

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 8.1.2. Market Attractiveness Index, By Application
8.2. Hernia Repair*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Pelvic Organ Prolapse Repair
8.4. Stress Urinary Incontinence
8.5. Others

9. By End-User

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.1.2. Market Attractiveness Index, By End-User
9.2. Hospitals*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Specialty Clinics
9.4. Ambulatory Surgical Centers
9.5. Others

10. By Region

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 10.1.2. Market Attractiveness Index, By Region
10.2. North America
- 10.2.1. Introduction
- 10.2.2. Key Region-Specific Dynamics
- 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
- 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.2.7.1. U.S.
  - 10.2.7.2. Canada
  - 10.2.7.3. Mexico
10.3. Europe
- 10.3.1. Introduction
- 10.3.2. Key Region-Specific Dynamics
- 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
- 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.3.7.1. Germany
  - 10.3.7.2. U.K.
  - 10.3.7.3. France
  - 10.3.7.4. Spain
  - 10.3.7.5. Italy
  - 10.3.7.6. Rest of Europe
10.4. South America
- 10.4.1. Introduction
- 10.4.2. Key Region-Specific Dynamics
- 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
- 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.4.7.1. Brazil
  - 10.4.7.2. Argentina
  - 10.4.7.3. Rest of South America
10.5. Asia-Pacific
- 10.5.1. Introduction
- 10.5.2. Key Region-Specific Dynamics
- 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
- 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.5.7.1. China
  - 10.5.7.2. India
  - 10.5.7.3. Japan
  - 10.5.7.4. South Korea
  - 10.5.7.5. Rest of Asia-Pacific
10.6. Middle East and Africa
- 10.6.1. Introduction
- 10.6.2. Key Region-Specific Dynamics
- 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
- 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape

11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis

12. Company Profiles

12.1. Johnson & Johnson*
- 12.1.1. Company Overview
- 12.1.2. Product Portfolio and Description
- 12.1.3. Financial Overview
- 12.1.4. Key Developments
12.2. B. Braun SE
12.3. Medtronic plc
12.4. Becton, Dickinson and Company
12.5. CITEC
12.6. W. L. Gore & Associates, Inc.
12.7. Medcity Surgicals
12.8. Dolphin Sutures
12.9. Herniamesh S.r.l.
12.10. Advin Health Care (LIST NOT EXHAUSTIVE )